Cash Flow Statement
Quarterly Data
The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.
The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.
Paying user area
Try for free
AbbVie Inc. pages available for free this week:
- Balance Sheet: Assets
- Common-Size Income Statement
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Analysis of Geographic Areas
- Capital Asset Pricing Model (CAPM)
- Dividend Discount Model (DDM)
- Present Value of Free Cash Flow to Equity (FCFE)
- Operating Profit Margin since 2012
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to AbbVie Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
AbbVie Inc., consolidated cash flow statement (quarterly data)
US$ in millions
Based on: 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).
- Net Earnings (Loss)
- Net earnings exhibit substantial volatility over the period analyzed, with both sharp declines and recoveries. A notably severe loss appeared in the second quarter of 2020, followed by a return to profitability. Earnings peaked at certain points, such as in the fourth quarter of 2021, but decreased markedly towards the end of the timeline, culminating in a negative result in the first quarter of 2025.
- Depreciation and Amortization
- Depreciation shows a relatively stable trend with minor fluctuations, suggesting consistent asset usage and capital expenditure patterns. Amortization of intangible assets remains at elevated levels throughout, with peaks in early quarters of 2020, indicating ongoing intangible asset amortization likely related to acquisitions or investments.
- Deferred Income Taxes
- Deferred income taxes fluctuate with occasional large negative movements, particularly during 2020 and late 2021. These movements indicate variable timing differences in income tax recognition and potential tax strategy changes.
- Change in Fair Value of Contingent Consideration Liabilities
- The fair value shows highly volatile changes, including significant positive spikes in late 2020 and early 2023. This volatility suggests active acquisitions or adjustments in acquisition-related liabilities.
- Payments of Contingent Consideration Liabilities
- Payments increase gradually over time, especially from 2022 onwards, reflecting the settlement of obligations related to prior acquisitions.
- Stock-Based Compensation
- Stock-based compensation expenses vary over the periods with no clear upward or downward trend, reflecting adjustments in employee compensation mechanisms.
- Acquired In-Process Research and Development (IPR&D) and Milestones
- Expenses related to acquired IPR&D and milestones show considerable variability, with spikes notably in early 2025. Periodic increases are indicative of ongoing investment in developmental assets and possible milestone payments linked to collaboration agreements.
- Impairment of Intangible Assets
- Impairment charges occur sporadically but include significant spikes in 2023 and early 2025. This pattern points to periodic asset write-downs potentially due to reassessment of intangible asset values or changes in expected cash flows.
- Changes in Working Capital (Accounts Receivable, Inventories, Prepaid Expenses, Accounts Payable)
- Accounts receivable show fluctuating values, with notable negative swings in early 2025, which could imply collection challenges or sales fluctuations. Inventories present no consistent directional trend but contain some periods of significant decreases. Prepaid expenses and other assets demonstrate irregular movements, sometimes large in absolute terms, indicating variable payment timing or asset reclassification. Accounts payable and other liabilities also fluctuate widely, with large positive and negative swings, especially in 2023 and early 2025, reflecting variability in payables management and operational activities.
- Operating Cash Flows
- Cash flows from operating activities generally remain strong and are considerably higher than net earnings, reflecting adjustments and non-cash items. Notably, operating cash flows reached peak levels in the quarters around 2022-2023, then displayed more variability with some quarters in 2025 declining sharply.
- Investing Activities
- Cash outflows related to acquisitions of businesses jumped sharply in the second quarter of 2020 and reappeared notably at the end of 2023, signaling large acquisition activities during these periods. Other investing activities show more modest and irregular cash outflows mainly driven by acquisitions of property and equipment. Sales and maturities of investment securities occasionally offset purchases with large inflows, particularly in 2022.
- Financing Activities
- Financing cash flows predominantly reflect dividend payments, which have steadily increased over time, suggesting a consistent return to shareholders policy. Debt repayment activity is sizeable in many quarters, counterbalanced by periodic debt issuances, particularly long-term debt spikes in mid-2024. Share repurchases are also considerable, with some quarters showing large treasury stock acquisitions, notably end of 2022 and 2023. Overall, financing activities exhibit substantial cash outflows with intermittent inflows due to debt issuances and stock option exercises.
- Net Change in Cash and Equivalents
- The net change in cash and equivalents is characterized by sharp swings from large decreases in early 2020 to strong increases in mid-to-late 2022 and early 2023. The balance appears sensitive to major financing and investing transactions and fluctuates more widely in 2024 and 2025.